SHORT STATEMENT OF THE FIRST EUROPEAN CONSENSUS CONFERENCE ON THE TREATMENT OF CHRONIC HEPATITIS B AND C IN HIV CO-INFECTED PATIENTS

☆ In our strive to keep our readership aware of the developments on the management of liver disease in patients co-infected with HIV, the Journal of Hepatology endeavoured to publish a concise statement generated by members of the Jury of the First European Consensus Conference on treatment of HBV and HCV in HIV co-infected patients. This document was distributed as a loose leaflet insert in the abstract book of the EASL Annual Meeting and is published bound in the current issue of the Journal of Hepatology for reference—Mario U. Mondelli, Co-Editor.

 Endorsed by the European Association for the Study of the Liver (EASL), the European AIDS Clinical Society (EACS), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the European Federation of Internal Medicine (EFIM), the International AIDS Society (IAS), the French Society of Infectious Diseases (SPILF) and the European AIDS Treatment Group (EATG). Hosting societies include the French Association for the Study of Liver Disease (AFEF) and the French Society of Internal Medicine (SNFMI). Supported by the French Agency for Research on AIDS (ANRS) and the French Ministry of Health.

PII: S0168-8278(05)00142-X

doi: 10.1016/j.jhep.2005.03.003

© 2005 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.